
Uniway Pharmaceuticals Private Limited
About Uniway Pharmaceuticals Private Limited
Data last updated:
Uniway Pharmaceuticals Private Limited was a private limited company based in Patna, Bihar, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 17 June 2015.
The company was registered with the Registrar of Companies (ROC), Patna, under CIN U51909BR2015PTC024430. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It was led by directors Ashfaque Ahmad Momin (Managing Director) and Jawaid Iqbal Wajidi.
Its last annual general meeting (AGM) was held on 30 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Flat No. 102 1st Floor Zenith Appartment Sultanganj Mahendru, Patna, Bihar, India – 800006.
As per the financials filed for FY 2018, the company reported a revenue of ₹13.91 Lakh, a decline of 55% compared to the previous year. For the same year it recorded a net loss of ₹27,852 (net margin -2%) and EBITDA of ₹30,547 (EBITDA margin 2.2%).
Company details
Contact details
Uniway Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 102 1st Floor Zenith Appartment Sultanganj Mahendru, Patna, Bihar, India – 800006
- IndustryChemicals, Medicinal Chemical & Botanical Products, Chemical Products, Pharmaceuticals
To see the full contact details of Uniway Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Uniway Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Uniway Pharmaceuticals Private Limited, buy the company report.
Financials of Uniway Pharmaceuticals Private Limited
FY 2018 filings availableUniway Pharmaceuticals Private Limited reported revenue of ₹13.91 Lakh (down 55% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue fell 55% in the latest year. EBITDA fell 70% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹30,547 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹27,852 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 2.2% | ||
| Net Profit Margin | -2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Uniway Pharmaceuticals Private Limited, buy the company report.
Board of directors of Uniway Pharmaceuticals Private Limited
Uniway Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jawaid Iqbal Wajidi | Director | 17 Jun 2015 | 11 Years 4 Months | As last reported |
| Ashfaque Ahmad Momin Also directs: Rainbow Emergency & Trauma Hospital Private Limited | Managing Director | 17 Jun 2015 | 11 Years 4 Months | As last reported |
Peer comparison
Uniway Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dbrmd Pharmaceuticals Private Limited | ₹13.95 Lakh (FY 2018) | Kolkata, West Bengal, India | ||||
| Qrent Pharmaceuticals Private Limited | ₹13.93 Lakh (FY 2024) | 66.0% | Gurugram, Haryana, India | |||
| Uniway Pharmaceuticals Private Limitedthis company | ₹13.91 Lakh (FY 2018) | -₹27,852 | -2% | -55.0% | Patna, Bihar, India | |
| Biovams Pharmaceuticals Private Limited | ₹13.9 Lakh (FY 2025) | -87.0% | Ahmedabad, Gujarat, India | |||
| Crinat Pharmaceuticals Private Limited | ₹13.89 Lakh (FY 2025) | -3.0% | Namakkal, Tamil Nadu, India | |||
| Decorum Pharmaceuticals Private Limited | ₹13.87 Lakh (FY 2024) | -5.0% | Patna, Bihar, India |
To see the full peer comparison of Uniway Pharmaceuticals Private Limited, buy the company report.
Auditor
Uniway Pharmaceuticals Private Limited is audited by GUPTA SACHDEVA & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUPTA SACHDEVA & CO | FY 2017 | 006706N |
Shareholding
The shareholding of Uniway Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Uniway Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Uniway Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Uniway Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Uniway Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Uniway Pharmaceuticals Private Limited, buy the company report.
Recent activity
Uniway Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Ashfaque Ahmad Momin was appointed as Managing Director on 17 Jun 2015.
Frequently asked questions
Uniway Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Uniway Pharmaceuticals was a private limited company based in Patna, Bihar, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 17 June 2015 and is registered under CIN U51909BR2015PTC024430. The company has been struck off by the Registrar of Companies and is no longer operational.
Uniway Pharmaceuticals had 2 directors:
- Ashfaque Ahmad Momin - Managing Director
- Jawaid Iqbal Wajidi - Director
The CIN (Corporate Identification Number) of Uniway Pharmaceuticals is U51909BR2015PTC024430. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Uniway Pharmaceuticals is at Flat No. 102 1st Floor Zenith Appartment Sultanganj Mahendru, Patna, Bihar, India – 800006.
Uniway Pharmaceuticals was incorporated on 17 June 2015. It is registered with the Registrar of Companies, Patna.
The latest financial statements of Uniway Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 30 September 2018. Year-wise statements from FY 2016 are in the company report.
No. Uniway Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
Uniway Pharmaceuticals operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
The peers of Uniway Pharmaceuticals by revenue are Dbrmd Pharmaceuticals Private Limited, Qrent Pharmaceuticals Private Limited, Biovams Pharmaceuticals Private Limited, Crinat Pharmaceuticals Private Limited, Decorum Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ashfaque Ahmad Momin was appointed as Managing Director on 17 Jun 2015. Jawaid Iqbal Wajidi was appointed as Director on 17 Jun 2015.

